Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 6 June 2015, Vol 294, No 7865

Sort by: Newest first Oldest first A-Z Z-A

  • NPA research bursary Subscription

    27 MAY 2015 13:44

    Applications for the National Pharmacy Association’s (NPA) Health Education Foundation Bursary are now open to registered pharmacists. The £10,000 bursary aims to support registered pharmacists who have an interest in developing their skills to undertake research relating to community pharmacy practice. An application pack can be downloaded from ...

  • AWMSG medicines approvals Subscription

    27 MAY 2015 13:40

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): bedaquiline for pulmonary multidrug‑resistant tuberculosis in adult patients as part of an appropriate combination regimen; daclatasvir for chronic hepatitis C virus infection in adults with significant fibrosis or compensated cirrhosis (as part of combination treatment); defibrotide for severe hepatic veno-occlusive disease alongside haematopoietic stem-cell transplantation ...

  • Advice on high-dose ibuprofen updated Subscription

    27 MAY 2015 13:36

    Advice on ibuprofen will be updated in Europe following final approval by the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (part of the European Medicines Agency). Updated advice was recommended by the Pharmacovigilance Risk Assessment Committee (PRAC) following a review by PRAC that confirmed an increased risk of cardiovascular problems at doses at or above 2,400mg of ibuprofen a day. Higher doses of ibuprofen should be avoided in patients with underlying ...

  • New medicines fund increased in Scotland Subscription

    27 MAY 2015 13:32

    The Scottish Government will double the amount of money available to fund treatments for people with rare or end-of-life conditions by increasing the new medicines fund to £80m for 2015–2016. More information is available from the Scottish Government’s website.

  • Medicines optimisation for patients with insomnia Subscription

    27 MAY 2015 13:26

    Keele University, with support from Flynn Pharma, has developed a guide for healthcare professionals about medicines optimisation in patients with insomnia. The guide is available for free at:

  • Risk of haemorrhage with Vitamin E and anticoagulants Subscription

    27 MAY 2015 13:22

    According to the updated summary of product characteristics, Vitamin E (DL-alpha-tocopheryl acetate; Alliance) suspension 100mg/ml may increase the risk of haemorrhage in patients taking anticoagulants. A possible adjustment of the dose of anticoagulants during and after treatment with Vitamin E may be necessary.

  • Thursday 18 June: RPS Faculty webinar Subscription

    27 MAY 2015 12:12

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘RPS Faculty membership – what are benefits?’ Find out what the Faculty is and how it fits and benefits your professional development and recognition. Online 7–8pm. To find out more information and to register and access the webinar, visit the RPS website.

  • The Royal Pharmaceutical Society has announced the results of the 2015 English Pharmacy Board election. Chair of the board David Branford (pictured) lost his seat after his five-year term, two of those as chairman, after receiving 13.9% of the vote.

    English Pharmacy Board election results are announced Subscription

    26 MAY 2015 17:07
    Comments (2)

    The Royal Pharmaceutical Society has announced the results of the 2015 English Pharmacy Board election, as voter turnout marginally rose but remained low.

  • New legislation governing how poisons and chemicals can be supplied by pharmacies have been clarified in guidance from the Royal Pharmaceutical Society (RPS). Nitric acid (pictured) is now a regulated substance under the explosive pre-cursor category

    Guidance clarifies new rules for pharmacies selling poisons and chemicals Subscription

    26 MAY 2015 16:42 By Stephen Robinson

    Changes in legislation prompt the RPS to publish guidance for pharmacists.

  • Europe undertakes review of diabetes drugs after ketoacidosis cases emerge. Simon O’Neill (pictured), from Diabetes UK, said: “It is important that people with diabetes do not stop taking their medication without consulting their doctor."

    EMA to review diabetes drugs after cases of ketoacidosis Subscription

    26 MAY 2015 14:39 By Debbie Andalo

    A spate of acidosis cases in the United States has sparked a review by the European Medicines Agency into reported incidences of potentially life-threatening ketoacidosis linked to drugs used to treat type 2 diabetes.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.